Document Detail


Estimation of glomerular filtration rate in obese patients with chronic renal impairment based on serum cystatin C levels.
MedLine Citation:
PMID:  15356965     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Serum cystatin C (Scyst) has an obvious advantage in recognizing the initial stages of renal impairment. However, several recent studies suggest that Scyst may also be affected by some nonglomerular factors such as thyroid dysfunction, glucocorticoid administration or metabolic status of the diabetic patient. The aim of this study was to evaluate whether obesity could affect Scyst. PATIENTS AND METHODS: The study was performed in 33 patients (mean age 49.1 +/- 6.3 years) with chronic renal disease (Scr = 227 +/- 118 micromol/l) and BMI = 35.6 +/- 1.8 kg/m2, and in 78 patients (mean age 43.4 +/- 5.1 years) with chronic renal disease (Scr = 245 +/- 111 micromol/l) and BMI = 24.0 +/- 1.8 kg/m2. Glomerular filtration rate (GFR) was determined using renal inulin clearance (Cin) under conditions of stabilized plasma concentrations and water loading. Scyst was measured using immunonephelometry. For statistical evaluation, linear regression analysis and receiver-operating characteristic (ROC) curve analysis were used. RESULTS: A significant correlation (r = 0.956, p < 0.001) between l/Scyst and Cin was demonstrated in patients with BMI > or = 30 kg/m2 (Group A). Similarly, a significant correlation (r = 0.900, p < 0.001) between l/Scys and Cin was found in patients with BMI < 30 kg/m2 (Group B). There was no significant difference between the regression straight lines characterizing these relationships. ROC curve analysis (using a cut-off value for Cin = 30 ml/min/1.73 m2) did not show significant differences in AUC, sensitivity and specificity for Scyst between obese and nonobese patients. CONCLUSION: The results suggest that evaluation of GFR based on Scyst in obese patients need not differ from that in nonobese ones.
Authors:
O Schück; V Teplan; M Stollova; J Skibova
Related Documents :
21353595 - Interleukin-6 and the matrix metalloproteinase response in the vitreous during prolifer...
3076965 - Treatment of cutaneous neoplasia with etretinate in renal transplant recipients.
21454215 - Phase i study of atacicept in relapsed/refractory multiple myeloma (mm) and waldenströ...
21385545 - Copy number variation of β-defensin genes in behçet's disease.
1061645 - Some cases of type iii glycogen storage disease.
8650715 - Neuroexcitatory amino acids and their relation to infarct size and neurological deficit...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical nephrology     Volume:  62     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2004-09-10     Completed Date:  2005-02-03     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  92-6     Citation Subset:  IM    
Affiliation:
Institute for Clinical and Experimental Medicine, Prague, Czech Republic. otto.schuck@medicon.cz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Chronic Disease
Cystatin C
Cystatins / blood*
Female
Glomerular Filtration Rate*
Humans
Kidney Diseases / blood*,  complications,  physiopathology*
Male
Middle Aged
Obesity / complications,  physiopathology*
Chemical
Reg. No./Substance:
0/CST3 protein, human; 0/Cystatin C; 0/Cystatins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasma leptin concentration in patients with acute renal failure.
Next Document:  A simple method for correcting overestimated glomerular filtration rate in obese subjects evaluated ...